Naoto Okada

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Venues

Basic & clinical pharmacology & toxicology

Cancer medicine

Open forum infectious diseases

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Naoto Okada, Tomoyuki Yanagi, Takaaki Sasaki, Miho Tamura, Masakazu Ozaki, Atsuyuki Saisyo, Takashi Kitahara
Association between immune checkpoint inhibitor and cytomegalovirus infection: A pharmacovigilance study based on the adverse event reporting system. International journal of cancer (2024)
Naoto Okada, Takahiro Niimura, Atsuyuki Saisyo, Yoshitaka Kawaguchi, Keisuke Ishizawa, Takashi Kitahara
Pharmacovigilance Study on Eosinophilic Pneumonia Induced by Anti-MRSA Agents: Analysis Based on the FDA Adverse Event Reporting System. Open forum infectious diseases 10 (8) (2023)
Yasunobu Kouki, Naoto Okada, Kosuke Saga, Masakazu Ozaki, Atsuyuki Saisyo, Takashi Kitahara
Disproportionality analysis on hypothyroidism with roxadustat using the japanese adverse drug event database. Journal of clinical pharmacology (2023)
Miho Tamura, Susumu Murata, Chihiro Ota, Shoko Tanaka, Hitomi Arichika, Daiki Hakuno, Naoto Okada, Kentaro Ushijima, Yasuhiro Tsuji, Takashi Kitahara
Relationship between prolonged gestation and nifedipine pharmacokinetics in long-term tocolysis. Basic & clinical pharmacology & toxicology (2023)
Masayuki Chuma, Hirofumi Hamano, Takashi Bando, Masateru Kondo, Naoto Okada, Yuki Izumi, Shunsuke Ishida, Toshihiko Yoshioka, Mizuho Asada, Takahiro Niimura, Yoshito Zamami, Kenshi Takechi, Mitsuhiro Goda, Koji Miyata, Kenta Yagi, Sachiko Kasamo, Yuki Izawa-Ishizawa, Momoyo Azuma, Hiroaki Yanagawa, Yoshikazu Tasaki, Keisuke Ishizawa
Non-recovery of vancomycin-associated nephrotoxicity is related to worsening survival outcomes: Combined retrospective analyses of two real-world databases. Basic & clinical pharmacology & toxicology 131 (6) (2022)
Naoto Okada, Momoyo Azuma, Kaito Tsujinaka, Akane Abe, Mari Takahashi, Yumiko Yano, Masami Sato, Takahiro Shibata, Mitsuhiro Goda, Keisuke Ishizawa
Clinical Impact of a Pharmacist-Driven Prospective Audit with Intervention and Feedback on the Treatment of Patients with Bloodstream Infection. Antibiotics (Basel, Switzerland) 11 (9) (2022)
Kenta Yagi, Marin Mitstui, Yoshito Zamami, Takahiro Niimura, Yuki Izawa-Ishizawa, Mitsuhiro Goda, Masayuki Chuma, Kimiko Fukunaga, Takahiro Shibata, Shunsuke Ishida, Takumi Sakurada, Naoto Okada, Hirofumi Hamano, Yuya Horinouchi, Yasumasa Ikeda, Hiroaki Yanagawa, Keisuke Ishizawa
Investigation of drugs affecting hypertension in bevacizumab-treated patients and examination of the impact on the therapeutic effect. Cancer medicine 10 (1) (2020)
Naoto Okada, Masayuki Chuma, Momoyo Azuma, Shingen Nakamura, Hirokazu Miki, Hirofumi Hamano, Mitsuhiro Goda, Kenshi Takechi, Yoshito Zamami, Masahiro Abe, Keisuke Ishizawa
Effect of serum concentration and concomitant drugs on vancomycin-induced acute kidney injury in haematologic patients: a single-centre retrospective study. European journal of clinical pharmacology 75 (12) (2019)
Naoto Okada, Takahiro Niimura, Yoshito Zamami, Hirofumi Hamano, Shunsuke Ishida, Mitsuhiro Goda, Kenshi Takechi, Masayuki Chuma, Masaki Imanishi, Keisuke Ishizawa
Pharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR-ABL inhibitor use by using an adverse drug event reporting database. Cancer medicine 8 (1) (2018)

Naoto Okada.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Naoto Okada